{"pub": "investing.com", "url": "https://au.investing.com/news/stock-market-news/briefcspc-pharmaceuticals-investigational-new-drug-almb0166-gets-clinical-trial-approval-in-australia-1975684", "downloaded_at": "2019-10-21 11:32:03.948202+00:00", "title": "BRIEF-CSPC Pharmaceutical's Investigational New Drug ALMB-0166 Gets Clinical Trial Approval In Australia", "language": "en", "text": "BRIEF-CSPC Pharmaceutical's Investigational New Drug ALMB-0166 Gets Clinical Trial Approval In Australia\n\nStock Markets 18 minutes ago (Oct 21, 2019 22:14)\n\n\u00a9 Reuters. BRIEF-CSPC Pharmaceutical's Investigational New Drug ALMB-0166 Gets Clinical Trial Approval In Australia Oct 21 (Reuters) - CSPC Pharmaceutical Group Ltd : * INVESTIGATIONAL NEW DRUG ALMB-0166 WAS GRANTED CLINICAL TRIAL APPROVAL IN AUSTRALIA * ALAMAB ALSO PLANS TO INITIATE RELEVANT CLINICAL TRIALS FOR ALMB-0166 IN CHINA, U.S. AND OTHER COUNTRIES\n\nBRIEF-CSPC Pharmaceutical's Investigational New Drug ALMB-0166 Gets Clinical Trial Approval In Australia", "description": "BRIEF-CSPC Pharmaceutical's Investigational New Drug ALMB-0166 Gets Clinical Trial Approval In Australia", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXNPEB66095_L.jpg", "published_at": "2019-10-21"}